EUVIMEDEUVIMED entdecken
Crossref

Eugenol alleviates the symptoms of experimental autoimmune encephalomyelitis in mice by suppressing inflammatory responses

Jihye Lee, Sungmoo Hong, Meejung Ahn, Jeongtae Kim, Changjong Moon, Hiroshi Matsuda, Akane Tanaka, Yoshihiro Nomura, Kyungsook Jung, Taekyun Shin

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2023.111479 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Jihye Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Functional Biomaterials Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 181 Ipsin-gil, Jeongeup-si, Jeonbuk 56212,…. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Multiple Sclerosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Korea Research Institute of Bioscience and Biotechnology, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Eugenol is a principal compound in essential clove oil, known for its anti-inflammatory and antioxidant properties. While recent studies have demonstrated its neuroprotective effects on central nervous system (CNS) injuries, such as brain ischemia/reperfusion injuries, but its potential impact on multiple sclerosis (MS), an autoimmune disease of the CNS, has not yet been explored. We evaluated the therapeutic effects of eugenol on experimental autoimmune encephalomyelitis (EAE), an established animal model of MS. EAE was induced in C57BL/6 mice using the myelin oligodendrocyte glycoprotein (MOG)35-55 peptide. Clinical symptoms, including paralysis, were monitored daily, and levels of pro-inflammatory mediators were evaluated using real-time quantitative polymerase chain reaction, Western blot analyses, and immunohistochemistry. Daily oral administration of eugenol to MOG-induced EAE mice led to a notable decline in the severity of clinical symptoms. Eugenol inhibited EAE-related immune cell infiltration and the production of pro-inflammatory mediators. Histological examinations confirmed its ability to mitigate inflammation and demyelination in the spinal cord post-EAE induction. Eugenol alleviates neuroinflammation in the spinal cords of EAE-induced mice, primarily through anti-inflammatory action.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Encephalomyelitis, Autoimmune, ExperimentalMultiple SclerosisMiceAnimalsEugenolCytokinesMice, Inbred C57BLSpinal CordMyelin-Oligodendrocyte GlycoproteinAnti-Inflammatory AgentsInflammation Mediators

Stichwörter der Autor:innen

EugenolExperimental autoimmune encephalomyelitisInflammationMultiple sclerosis

Substanzen

EugenolCytokinesMyelin-Oligodendrocyte GlycoproteinAnti-Inflammatory AgentsInflammation Mediators

Autor:innen und Institutionen

  • Functional Biomaterials Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 181 Ipsin-gil, Jeongeup-si, Jeonbuk 56212, Republic of Korea.
  • College of Veterinary Medicine and Veterinary Medical Research Institute, Jeju National University, Jeju 63243, Republic of Korea.
  • Department of Animal Science, College of Life Science, Sangji University, Wonju 26339, Republic of Korea.
  • Department of Anatomy, Kosin University College of Medicine, Busan 49267, Republic of Korea.
  • Department of Veterinary Anatomy and Animal Behavior, College of Veterinary Medicine and BK21 Plus Project Team, Chonnam National University, Gwangju 61186, Republic of Korea.
  • Laboratory of Comparative Animal Medicine, Division of Animal Life Science, Faculty of Agriculture, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu, Tokyo 183-8509, Japan.

Förderung

  • Korea Research Institute of Bioscience and Biotechnology
  • National Research Foundation of Korea

Zitieren

APA

Lee, J., Hong, S., Ahn, M., Kim, J., Moon, C., Matsuda, H., Tanaka, A., Nomura, Y., Jung, K., & Shin, T. (2024). Eugenol alleviates the symptoms of experimental autoimmune encephalomyelitis in mice by suppressing inflammatory responses. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.111479

Vancouver

Lee J, Hong S, Ahn M, Kim J, Moon C, Matsuda H, et al. Eugenol alleviates the symptoms of experimental autoimmune encephalomyelitis in mice by suppressing inflammatory responses. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2023.111479

BibTeX
@article{Lee2024,
  author = {Lee, Jihye and Hong, Sungmoo and Ahn, Meejung and Kim, Jeongtae and Moon, Changjong and Matsuda, Hiroshi and Tanaka, Akane and Nomura, Yoshihiro and Jung, Kyungsook and Shin, Taekyun},
  title = {Eugenol alleviates the symptoms of experimental autoimmune encephalomyelitis in mice by suppressing inflammatory responses},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2023.111479}
}
Kostenlos starten →